Elevance Health, Inc.
ELVHealthcareelevancehealth.com
Latest available resultsSeptember 30, 2026Quarter · 10-Q filed Oct 21, 2026
Next reportJanuary 26, 2027after close · forecast 2.085 $/share
Revenue
$51.43B
▲ +1.4% vs prior year YoY
Net income
$1.36B
▲ +14.8% vs prior year YoY
EPS
6.27$
▲ +17.9% vs prior year YoY
Net margin
2.7%
▲ +0.3 pp vs prior year YoY
Revenue▲ +1.4%
Margins (% of revenue)GrossOperatingNet
Net income▲ +14.8%
EPS▲ +17.9%
Financial statements
View 10-Q filed October 21, 2026 on SEC ↗| Metric | Dec 2024* | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025* | Mar 2026 | Jun 2026 | Sep 2026 | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Operations | |||||||||
| Revenue | $45.44B | $48.89B | $49.78B | $50.71B | $49.75B | $50.18B | $50.47B | $51.43B | ▲ +1.4% |
| Gross profit | $39.43B | $43.91B | $44.48B | $45.33B | $44.23B | $44.72B | $44.98B | $45.79B | ▲ +1.0% |
| Operating income | $673.00M | $3.17B | $2.42B | $1.29B | $309.00M | $2.09B | $1.76B | $1.27B | ▼ -2.0% |
| Net income | $418.00M | $2.18B | $1.74B | $1.19B | $547.00M | $1.76B | $1.46B | $1.36B | ▲ +14.8% |
| R&Dnever filed | — | — | — | — | — | — | — | — | — |
| EPS (diluted) | — | 9.61 $ | 7.72 $ | 5.32 $ | — | 8.00 $ | 6.71 $ | 6.27 $ | ▲ +17.9% |
| Margins (% of revenue) | |||||||||
| Gross | 86.8 % | 89.8 % | 89.4 % | 89.4 % | 88.9 % | 89.1 % | 89.1 % | 89.0 % | ▼ -0.4 pt |
| Operating | 1.5 % | 6.5 % | 4.9 % | 2.6 % | 0.6 % | 4.2 % | 3.5 % | 2.5 % | ▼ -0.1 pt |
| Net | 0.9 % | 4.5 % | 3.5 % | 2.3 % | 1.1 % | 3.5 % | 2.9 % | 2.7 % | ▲ +0.3 pt |
| Balance sheet | |||||||||
| Assets | $116.89B | $119.72B | $121.94B | $122.75B | $121.49B | $125.83B | $126.44B | $127.80B | ▲ +4.1% |
| Liabilities | $75.46B | $77.10B | $78.09B | $78.67B | $77.47B | $81.78B | $81.42B | $83.01B | ▲ +5.5% |
| Equity | $41.43B | $42.62B | $43.85B | $44.08B | $44.03B | $44.04B | $45.02B | $44.79B | ▲ +1.6% |
| Cash | $8.29B | $7.50B | $8.56B | $8.71B | $9.49B | $9.66B | $10.23B | $10.35B | ▲ +18.8% |
| Capital | |||||||||
| Shares outstanding | 227.35M | 225.93M | 225.18M | 222.24M | 220.70M | 217.16M | 216.87M | 216.06M | ▼ -2.8% |
| Public floatexcluding insiders | — | — | — | — | — | — | — | — | — |
* No 10-Q is filed for a fourth quarter: these amounts are the fiscal year minus the first three quarters, all filed. EPS stays blank — dilution doesn't subtract.